1 Effectiveness of antidementia drugs in delaying Alzheimers disease progression Alzheimer's & Dementia, May 2, 2013
2 A randomized, double-blind, placebo-controlled trial of memantine in a behaviorally enriched sample of patients with moderate-to-severe Alzheimers disease International Psychogeriatrics, April 23, 2013
3 Diabetes mellitus and risk of dementia: A meta-analysis of prospective observational studies Journal of Diabetes Investigation, April 29, 2013 Evidence Based Medicine Review Article
4 Heart-type fatty acid binding protein and vascular endothelial growth factor: cerebrospinal fluid biomarker candidates for Alzheimers disease European Archives of Psychiatry and Clinical Neuroscience, April 19, 2013
5 Subgroups of Alzheimers Disease Associated with Diabetes Mellitus Based on Brain Imaging Dementia and Geriatric Cognitive Disorders, April 30, 2013 Review Article
6 A Double-Blind, Placebo-Controlled, Ascending-Dose, Randomized Study to Evaluate the Safety, Tolerability and Effects on Cognition of AL-108 after 12 Weeks of Intranasal Administration in Subjects with Mild Cognitive Impairment Dementia and Geriatric Cognitive Disorders, April 30, 2013
7 Repetitive transcranial magnetic stimulation combined with cognitive training is a safe and effective modality for the treatment of Alzheimers disease: a randomized, double-blind study Journal of Neural Transmission, April 25, 2013
8 Effectiveness and Safety of Memantine Treatment for Alzheimers Disease Journal of Alzheimer’s Disease, May 15, 2013
9
A blood-based predictor for neocortical Aβ burden in Alzheimer’s disease: results from the AIBL study
Molecular Psychiatry, May 1, 2013
Exclusive Author Commentary
10 Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies The British Journal of Psychiatry, May 3, 2013 Evidence Based Medicine Review Article
Sponsor
Register now to view all the MDLinx contents (FREE)!
Login
Sponsor
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close
Sponsor